Kukje Pharma Revenue

Kukje Pharma had revenue of 41.50B KRW in the quarter ending March 31, 2025, with 10.58% growth. This brings the company's revenue in the last twelve months to 160.43B, up 14.19% year-over-year. In the year 2024, Kukje Pharma had annual revenue of 156.46B with 15.58% growth.

Revenue (ttm)

160.43B

Revenue Growth

+14.19%

P/S Ratio

0.60

Revenue / Employee

657.51M

Employees

244

Market Cap

97.03B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	156.46B	21.09B	15.58%
Dec 31, 2023	135.37B	8.79B	6.94%
Dec 31, 2022	126.58B	6.84B	5.71%
Dec 31, 2021	119.75B	-10.65B	-8.17%
Dec 31, 2020	130.39B	19.27B	17.34%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Samsung Biologics	4,898.69B
Celltrion	3,662.23B
ALTEOGEN	151.65B
Yuhan	2,114.76B
SK Biopharmaceuticals	578.00B
HLB Co., Ltd.	74.64B
PharmaResearch	392.31B
Peptron	4.30B

Revenue Rankings